Basal ganglia echogenicity in tauopathies

[1]  K. Szlachta,et al.  Brain tissue echogenicity—implications for substantia nigra studies in parkinsonian patients , 2011, Journal of Neural Transmission.

[2]  D. Berg,et al.  Microglia activation is related to substantia nigra echogenicity , 2010, Journal of Neural Transmission.

[3]  D. Dickson,et al.  Iron and reactive oxygen species activity in parkinsonian substantia nigra. , 2010, Parkinsonism & related disorders.

[4]  D. Berg,et al.  In vivo detection of iron and neuromelanin by transcranial sonography – a new approach for early detection of substantia nigra damage , 2006, Journal of Neural Transmission.

[5]  D. Berg,et al.  Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  D. Dressler,et al.  Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy , 2004, Neurology.

[7]  B U Meyer,et al.  Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes , 2002, Neurology.

[8]  G Becker,et al.  Vulnerability of the nigrostriatal system as detected by transcranial ultrasound , 1999, Neurology.

[9]  G Becker,et al.  Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography , 1995, Neurology.

[10]  Uwe Walter,et al.  Transcranial brain parenchyma sonography in movement disorders: state of the art. , 2007, Ultrasound in medicine & biology.